Asthma and COPD can significantly affect patients and pose a substantial economic burden for both patients and managed-care plans. This study compares utilization outcomes in patients with asthma, COPD, or co-occurring asthma and COPD in a Medicaid population, and assesses the incremental burden of COPD in patients with asthma.
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, Twelfth Floor, Baltimore, MD 21201, USA. fshaya@rx.umaryland.edu
